Xvivo Perfusion Fair Value
XV
The fair market value of XVIVO.ST stock is 1117.73 SEK. Relative to the market price of 502 SEK Xvivo Perfusion AB is undervalued by 122.7%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Xvivo Perfusion Valuation
Current XVIVO.ST share ticker price is 502 SEK.
The fair value level of 1117.73 SEK can be considered as an effective entry point for long-term investors to start investing in XVIVO.ST stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 123% lower its fair value
Current price is 16% higher its minimum value
Current price is 674% lower its maximum value
Market price:
XVIVO.ST stock is undervalued
It means the current price may concern as a Moderate Risk Entry Point
Xvivo Perfusion AB Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
984.77
2
Median P/E over 5 years
283.21
3
Minimum P/E over 5 years
106.32
4
Earning per share (last 12 months)
3.95 SEK
Maximum value
1
x
4
=
3 886.51 SEK
Fair value
2
x
4
=
1 117.73 SEK
Minimum value
3
x
4
=
419.62 SEK
Xvivo Perfusion AB price metrics
25.7
Annual return (geometric mean)
48.7
Risk (standard deviation) of returns
β
1.6
Beta (volatility compared to market)